Anti-Angiogenesis Therapy Using Thalidomide in Multiple Myeloma

Clinical trial NCT00083577 · COMPLETED

Trial details

NCT number: NCT00083577
Sponsor: University of Arkansas
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 1998-02-01
Enrollment: 250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.